Condition: Parkinson Disease · Sponsor: Amsterdam UMC, location VUmc
The majority of people with Parkinson's disease incur Freezing of Gait (FoG), which is not addressed adequately by medication. Cueing is a proven strategy to overcome FoG. The Cue2Walk is a device with automated detection of FoG and provision of rhythmic cues. In this study, the (cost-)effectiveness of the Cue2Walk device as compared to usual care is investigated.
This description comes directly from the study's public registry record.
Erwin EH van Wegen, PhD · 020-4440461 · e.vanwegen@amsterdamumc.nl
Always discuss trial participation with your own doctor first.
| Radboudumc | Nijmegen, Gelderland, Netherlands | Not Yet Recruiting |
| Amsterdam UMC, location VUmc | Amsterdam, North Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06416345